Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Lithium-ion batteries research set to improve ordinary lives
2016-02-11

Description: Dr Lehlohonolo Koao  Tags: Dr Lehlohonolo Koao

Dr Koao is making a much-needed contribution in improving lives of ordinary people through his research on lithium-ion batteries.

The future of relevant and top-notch scientific research at the Qwaqwa Campus is in good hands. Dr Lehlohonolo Koao is one of the five members of the Vice-Chancellor’s Prestige Scholars Programme (PSP) on the Qwaqwa Campus.

The need to improve the efficiency of heating mechanisms in his immediate community in Qwaqwa, and the support he receives from the PSP, have become catalysts for his current research project on lithium-ion batteries. According to Dr Koao, the study will focus on producing batteries that last longer, store more energy, are cheaper to manufacture, and are environmentally friendly when being disposed of. These are key factors in solar energy.

‘’The majority of households in my neighbourhood have benefited from the government’s project of providing households with solar panels to help with lighting, cooking, and heating without worrying about the ever-increasing electricity costs,’’ said Dr Koao.

‘’Since my arrival in the area, I have realized that the heat absorption rate of the batteries used by solar panels is not enough. As a result, these batteries also lack enough power to sustain the supply throughout the day, especially on a cloudy day,’’ he said.

His research project focuses on improving the efficiency of lithium-ion batteries that are now commonly used in portable electronics, such as cell phones and laptops. This kind of battery is rapidly replacing the usual lead-acid batteries. Dr Koao’s determination to contribute towards a safer and more efficient heating absorption system has made him move away completely from his PhD study on lighting material.

‘’My previous study was on reducing the power usage on domestic and industrial lights as they use more electricity. This study, on the other hand, will enhance power retention in the batteries for improved daily life since cell phones, solar panels, and laptops, to mention only a few, are now a way of life,’’ he added.

Dr Koao is a Senior Lecturer in the Department of Physics, where he specializes in solid state materials.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept